Back to search

Spain· ES:77308

RIVASTIGMINA TEVA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG

A medicinal product containing rivastigmina, registered in Spain by Teva Pharma S.L.U..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedRIVASTIGMINA TEVA 4,6 MG/24 H PARCHES…ATC—REGISTER NO.ES:77308PACKS LISTED2CHECKEDAugust 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
rivastigmina
Manufacturer
Teva Pharma S.L.U.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
August 12, 2026

Packs & prices · 2

2 priced
  • cima_codigo
    697310
    30
    EUR 33.17
  • cima_codigo
    697311
    60
    EUR 66.36

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rivastigmina in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rivastigmina products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Nimgista, Rivagelan
  • Belgium · Rivastigmin Sandoz, Rivastigmine Viatris
  • Bulgaria · Ридаксин
  • Germany · Demelora, Rivastigmin
  • Denmark · Rigmin, Rivastigmin Orion
  • Finland · Rivastigmin Orion, Rivastigmine Sandoz
  • France · Rivastigmine Arrow, Rivastigmine Biogaran
  • United Kingdom (Northern Ireland) · Almuriva, Alzest
  • Greece · Alapril, Balaxon
  • Iceland · Exelon, Nimvastid
  • Italy · Demelora, Rivastigmina Aurobindo
  • Liechtenstein · Exelon, Rivastigmine 1 A Pharma
  • Malta · Rivastigmine Aurobindo
  • Netherlands · Ristidic, Rivastgimine Neuraxpharm
  • Norway · Exelon, Nimvastid
  • Poland · Atmina, Evertas
  • Portugal · Nervopan, Rivastigmina Alter
  • Romania · Evertas, Ridaxin
  • Sweden · Rigmin, Rivastigmin Orion
  • Slovenia · Rivastigmin Teva, Rivastigmin Teva B.V.
  • Slovakia · Ristidic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9dac3ae-efa4-42d3-a5f0-ab3a00a72cbd
GET /v1/drugs/a9dac3ae-efa4-42d3-a5f0-ab3a00a72cbd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Diagnóstico Hospitalario",
  "estado": "{\"aut\":1363616577000}",
  "nregistro": "77308",
  "substance": "rivastigmina"
}

See everything about rivastigmina.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.